Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 26 | 2023 | 1593 | 2.750 |
Why?
|
| Cognition | 22 | 2023 | 1277 | 1.850 |
Why?
|
| Alzheimer Disease | 26 | 2023 | 1942 | 1.850 |
Why?
|
| Brain | 24 | 2023 | 1689 | 1.760 |
Why?
|
| White Matter | 8 | 2022 | 149 | 1.240 |
Why?
|
| Memory Disorders | 9 | 2018 | 174 | 1.220 |
Why?
|
| Aged | 55 | 2023 | 9448 | 1.100 |
Why?
|
| Mental Recall | 8 | 2008 | 74 | 1.080 |
Why?
|
| Magnetic Resonance Imaging | 23 | 2023 | 1221 | 1.050 |
Why?
|
| Attention | 5 | 2009 | 144 | 1.020 |
Why?
|
| Cognitive Dysfunction | 7 | 2023 | 938 | 1.020 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2023 | 81 | 0.970 |
Why?
|
| Aged, 80 and over | 38 | 2021 | 4851 | 0.960 |
Why?
|
| Gray Matter | 4 | 2016 | 56 | 0.850 |
Why?
|
| Neuropsychological Tests | 20 | 2022 | 1251 | 0.790 |
Why?
|
| Humans | 68 | 2023 | 29337 | 0.730 |
Why?
|
| Male | 51 | 2023 | 15621 | 0.710 |
Why?
|
| Prefrontal Cortex | 5 | 2018 | 152 | 0.690 |
Why?
|
| Visual Perception | 4 | 2007 | 50 | 0.690 |
Why?
|
| Female | 49 | 2023 | 16197 | 0.680 |
Why?
|
| Dementia | 6 | 2022 | 521 | 0.670 |
Why?
|
| Brain Mapping | 9 | 2021 | 195 | 0.650 |
Why?
|
| Acculturation | 3 | 2023 | 33 | 0.640 |
Why?
|
| Memory | 9 | 2021 | 318 | 0.610 |
Why?
|
| Semantics | 3 | 2008 | 20 | 0.560 |
Why?
|
| Motor Activity | 3 | 2015 | 369 | 0.550 |
Why?
|
| Genome-Wide Association Study | 7 | 2019 | 301 | 0.540 |
Why?
|
| Cues | 7 | 2007 | 61 | 0.540 |
Why?
|
| Neuroimaging | 4 | 2022 | 136 | 0.520 |
Why?
|
| Inflammation | 4 | 2022 | 344 | 0.520 |
Why?
|
| Cerebral Cortex | 2 | 2021 | 195 | 0.510 |
Why?
|
| Motor Skills | 1 | 2015 | 61 | 0.510 |
Why?
|
| Cognition Disorders | 11 | 2018 | 1011 | 0.460 |
Why?
|
| Hippocampus | 6 | 2022 | 274 | 0.450 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2023 | 219 | 0.440 |
Why?
|
| Geriatric Assessment | 3 | 2009 | 219 | 0.440 |
Why?
|
| Neural Pathways | 6 | 2014 | 83 | 0.410 |
Why?
|
| Vocabulary | 3 | 1999 | 14 | 0.360 |
Why?
|
| Anisotropy | 5 | 2023 | 58 | 0.360 |
Why?
|
| Longitudinal Studies | 10 | 2023 | 1442 | 0.360 |
Why?
|
| Pattern Recognition, Visual | 8 | 2005 | 31 | 0.360 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 117 | 0.340 |
Why?
|
| Functional Laterality | 2 | 2008 | 91 | 0.340 |
Why?
|
| Disease Progression | 3 | 2009 | 787 | 0.330 |
Why?
|
| Memory, Short-Term | 3 | 2021 | 102 | 0.330 |
Why?
|
| Reaction Time | 4 | 2021 | 123 | 0.330 |
Why?
|
| Activities of Daily Living | 3 | 2009 | 501 | 0.320 |
Why?
|
| Verbal Learning | 3 | 2004 | 42 | 0.310 |
Why?
|
| Loneliness | 2 | 2018 | 52 | 0.290 |
Why?
|
| Antibodies, Antiphospholipid | 2 | 2019 | 26 | 0.280 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2005 | 29 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 306 | 0.260 |
Why?
|
| Cohort Studies | 11 | 2019 | 1939 | 0.250 |
Why?
|
| Decision Making | 3 | 2016 | 220 | 0.240 |
Why?
|
| Parkinsonian Disorders | 1 | 2007 | 217 | 0.230 |
Why?
|
| Health Status | 2 | 2009 | 227 | 0.230 |
Why?
|
| Arteriolosclerosis | 1 | 2023 | 71 | 0.220 |
Why?
|
| Middle Aged | 16 | 2019 | 9823 | 0.220 |
Why?
|
| Entorhinal Cortex | 2 | 2017 | 37 | 0.220 |
Why?
|
| Adult | 13 | 2022 | 8601 | 0.210 |
Why?
|
| Genetic Variation | 2 | 2019 | 105 | 0.210 |
Why?
|
| Health Literacy | 1 | 2023 | 102 | 0.210 |
Why?
|
| Comprehension | 2 | 2016 | 28 | 0.200 |
Why?
|
| Linear Models | 4 | 2018 | 254 | 0.200 |
Why?
|
| Psychology | 1 | 2021 | 20 | 0.200 |
Why?
|
| Neuropathology | 2 | 2019 | 79 | 0.200 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2021 | 80 | 0.190 |
Why?
|
| Social Environment | 1 | 2021 | 79 | 0.190 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 18 | 0.180 |
Why?
|
| Parkinson Disease | 2 | 2016 | 1164 | 0.180 |
Why?
|
| Age Factors | 5 | 2016 | 843 | 0.180 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 20 | 0.180 |
Why?
|
| Hypertension | 1 | 2022 | 266 | 0.180 |
Why?
|
| Motor Disorders | 1 | 2019 | 22 | 0.170 |
Why?
|
| Lateral Ventricles | 1 | 2018 | 7 | 0.170 |
Why?
|
| Mental Status Schedule | 4 | 2018 | 113 | 0.170 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 402 | 0.170 |
Why?
|
| Genome, Human | 1 | 2018 | 49 | 0.160 |
Why?
|
| Statistics as Topic | 3 | 2011 | 113 | 0.160 |
Why?
|
| Actigraphy | 2 | 2016 | 98 | 0.160 |
Why?
|
| Delay Discounting | 1 | 2018 | 24 | 0.160 |
Why?
|
| Perceptual Disorders | 1 | 1997 | 7 | 0.160 |
Why?
|
| Reading | 4 | 2004 | 40 | 0.150 |
Why?
|
| Organ Size | 4 | 2019 | 107 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 441 | 0.150 |
Why?
|
| Amyloid | 1 | 2017 | 53 | 0.150 |
Why?
|
| Gene Expression | 1 | 2018 | 226 | 0.150 |
Why?
|
| Risk Factors | 3 | 2023 | 2443 | 0.150 |
Why?
|
| Nucleus Accumbens | 1 | 2016 | 25 | 0.150 |
Why?
|
| Perception | 1 | 1997 | 83 | 0.140 |
Why?
|
| Neurofibrillary Tangles | 1 | 2017 | 181 | 0.140 |
Why?
|
| Intelligence | 1 | 2016 | 25 | 0.140 |
Why?
|
| Economics | 1 | 2016 | 18 | 0.140 |
Why?
|
| Disability Evaluation | 2 | 2009 | 327 | 0.140 |
Why?
|
| Neocortex | 1 | 2016 | 34 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 43 | 0.140 |
Why?
|
| Cerebral Infarction | 2 | 2016 | 152 | 0.130 |
Why?
|
| Cognitive Aging | 1 | 2016 | 81 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 46 | 0.130 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 63 | 0.130 |
Why?
|
| Microglia | 1 | 2016 | 124 | 0.130 |
Why?
|
| Gyrus Cinguli | 1 | 2014 | 22 | 0.120 |
Why?
|
| Central Nervous System Agents | 1 | 2014 | 8 | 0.120 |
Why?
|
| Financial Management | 1 | 2014 | 24 | 0.120 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 14 | 0.120 |
Why?
|
| Pyridines | 1 | 2014 | 42 | 0.120 |
Why?
|
| Logistic Models | 1 | 2015 | 407 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 42 | 0.120 |
Why?
|
| Cerebellum | 1 | 2013 | 57 | 0.120 |
Why?
|
| Reward | 1 | 2013 | 34 | 0.120 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2013 | 26 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2007 | 959 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2013 | 56 | 0.110 |
Why?
|
| Epidemiologic Research Design | 1 | 2012 | 16 | 0.110 |
Why?
|
| Musculoskeletal Pain | 1 | 2012 | 20 | 0.110 |
Why?
|
| Verbal Behavior | 2 | 2005 | 19 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 1830 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2012 | 5 | 0.110 |
Why?
|
| Time Factors | 5 | 2013 | 1616 | 0.110 |
Why?
|
| Autopsy | 3 | 2018 | 335 | 0.100 |
Why?
|
| Risk-Taking | 1 | 2011 | 32 | 0.100 |
Why?
|
| Chronic Pain | 1 | 2012 | 112 | 0.100 |
Why?
|
| Movement Disorders | 1 | 2012 | 141 | 0.100 |
Why?
|
| Genetic Loci | 3 | 2017 | 61 | 0.100 |
Why?
|
| Muscle Strength | 2 | 2009 | 127 | 0.090 |
Why?
|
| Occipital Lobe | 3 | 1998 | 13 | 0.090 |
Why?
|
| Social Adjustment | 1 | 2009 | 28 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 389 | 0.090 |
Why?
|
| Evoked Potentials | 1 | 2008 | 18 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 55 | 0.080 |
Why?
|
| Biomarkers | 3 | 2019 | 689 | 0.080 |
Why?
|
| Depression | 2 | 2016 | 465 | 0.080 |
Why?
|
| Self Report | 2 | 2021 | 218 | 0.080 |
Why?
|
| Photic Stimulation | 2 | 2005 | 44 | 0.080 |
Why?
|
| Amnesia | 2 | 1998 | 27 | 0.080 |
Why?
|
| United States | 2 | 2021 | 2333 | 0.080 |
Why?
|
| Leg | 1 | 2007 | 49 | 0.080 |
Why?
|
| Probability | 2 | 2021 | 94 | 0.080 |
Why?
|
| Frontal Lobe | 2 | 2018 | 81 | 0.080 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 23 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2004 | 1113 | 0.070 |
Why?
|
| Temporal Lobe | 2 | 2018 | 105 | 0.070 |
Why?
|
| Mobility Limitation | 1 | 2007 | 97 | 0.070 |
Why?
|
| Psychometrics | 2 | 2004 | 262 | 0.070 |
Why?
|
| Independent Living | 2 | 2020 | 281 | 0.070 |
Why?
|
| Neurologic Examination | 1 | 2007 | 146 | 0.070 |
Why?
|
| Logic | 1 | 2004 | 3 | 0.070 |
Why?
|
| Atrophy | 1 | 2005 | 102 | 0.070 |
Why?
|
| Comorbidity | 1 | 2007 | 498 | 0.070 |
Why?
|
| Catholicism | 1 | 2004 | 21 | 0.070 |
Why?
|
| Religion and Psychology | 1 | 2004 | 24 | 0.060 |
Why?
|
| Clergy | 1 | 2005 | 90 | 0.060 |
Why?
|
| Reference Values | 1 | 2004 | 227 | 0.060 |
Why?
|
| Speech Perception | 1 | 2004 | 48 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2004 | 107 | 0.060 |
Why?
|
| Paired-Associate Learning | 1 | 2001 | 4 | 0.050 |
Why?
|
| Spatial Processing | 1 | 2021 | 6 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 26 | 0.050 |
Why?
|
| Oxygen | 2 | 2011 | 85 | 0.050 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2016 | 96 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2022 | 238 | 0.050 |
Why?
|
| Research Design | 1 | 2021 | 212 | 0.040 |
Why?
|
| Dissociative Disorders | 1 | 1998 | 4 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2018 | 21 | 0.040 |
Why?
|
| Demography | 1 | 2018 | 77 | 0.040 |
Why?
|
| Mental Processes | 1 | 1998 | 18 | 0.040 |
Why?
|
| Social Isolation | 1 | 2018 | 22 | 0.040 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2017 | 5 | 0.040 |
Why?
|
| Amyloidosis | 1 | 2017 | 27 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 21 | 0.040 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2017 | 7 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 1998 | 216 | 0.040 |
Why?
|
| Genome | 1 | 2016 | 15 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 12 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2017 | 58 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 33 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 48 | 0.040 |
Why?
|
| Epilepsy | 1 | 1997 | 104 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 24 | 0.040 |
Why?
|
| Transcriptome | 1 | 2016 | 83 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2016 | 14 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 153 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 173 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 756 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 355 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 125 | 0.030 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 3 | 1 | 2015 | 15 | 0.030 |
Why?
|
| Neoplasms | 1 | 2018 | 247 | 0.030 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2016 | 115 | 0.030 |
Why?
|
| Alleles | 1 | 2015 | 224 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 217 | 0.030 |
Why?
|
| Glucose | 1 | 2014 | 59 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 81 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 48 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 39 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 230 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 88 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 1184 | 0.030 |
Why?
|
| Sleep | 1 | 2016 | 313 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 503 | 0.030 |
Why?
|
| Child | 1 | 2017 | 1346 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 1811 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 41 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2012 | 58 | 0.030 |
Why?
|
| Games, Experimental | 1 | 2011 | 9 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 293 | 0.030 |
Why?
|
| Nerve Net | 1 | 2011 | 54 | 0.030 |
Why?
|
| Adolescent | 1 | 2017 | 2279 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 1932 | 0.020 |
Why?
|
| Animals | 1 | 2019 | 4552 | 0.020 |
Why?
|
| Word Association Tests | 2 | 1999 | 3 | 0.020 |
Why?
|
| Illinois | 1 | 2009 | 241 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 1998 | 321 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 1999 | 638 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2005 | 16 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 96 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 3478 | 0.020 |
Why?
|
| Chicago | 1 | 2007 | 865 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2005 | 343 | 0.020 |
Why?
|
| Personality Disorders | 1 | 2004 | 19 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 521 | 0.010 |
Why?
|
| Visual Cortex | 1 | 1998 | 8 | 0.010 |
Why?
|
| Visual Pathways | 1 | 1998 | 8 | 0.010 |
Why?
|
| Anomia | 1 | 1998 | 3 | 0.010 |
Why?
|
| Size Perception | 1 | 1998 | 2 | 0.010 |
Why?
|
| Orientation | 1 | 1998 | 10 | 0.010 |
Why?
|
| Concept Formation | 1 | 1998 | 11 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1998 | 96 | 0.010 |
Why?
|